Symptom relief in symptomatic mild reflux oesophagitis: Omeprazole 20 mg om more effective than high dose ranitidine 300 mg bid

被引：0

作者：

Festen, HPM

Tan, TG

Snel, P

Nelis, GF

机构：

[1] GROOT ZIEKEN GASTHUIS, DEPT INTERNAL MED, DEN BOSCH, NETHERLANDS

[2] STREEKZIEKENHUIS MIDDEN TWENTE, DEPT INTERNAL MED, HENGELO, NETHERLANDS

[3] SLOTERVAART HOSP, DEPT GASTROENTEROL, AMSTERDAM, NETHERLANDS

[4] SOPHIA HOSP, DEPT GASTROENTEROL, ZWOLLE, NETHERLANDS

来源：

GASTROENTEROLOGY | 1997年 / 112卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A117 / A117

页数：1

共 38 条

[21] Superiority of 20mg pantoprazole (PANTO) vs 150mg x 2 ranitidine (RANI) in healing and symptom relief of patients with mild reflux esophagitis.
Ramirez-Barba, EJ
Di Silvio, M
Dibildox, M
Moguel, A
Rodriguez, F
Almaguer, I
Andrade, P
Fischer, R
Klein, M
Wurst, W
GASTROENTEROLOGY, 1998, 114 (04) : A264 - A264
[22] Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
Kerstin Röhss
Tore Lind
Clive Wilder-Smith
European Journal of Clinical Pharmacology, 2004, 60 : 531 - 539
[23] Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
Röhss, K
Lind, T
Wilder-Smith, C
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (08) : 531 - 539
[24] DOES 40 MG OMEPRAZOLE DAILY OFFER ADDITIONAL BENEFIT OVER 20 MG DAILY IN PATIENTS REQUIRING MORE THAN 4 WEEKS OF TREATMENT FOR SYMPTOMATIC REFLUX ESOPHAGITIS
BATE, CM
BOOTH, SN
CROWE, JP
HEPWORTHJONES, B
TAYLOR, MD
RICHARDSON, PDI
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1993, 7 (05) : 501 - 507
[25] Cisapride 20 mg BID provides effective daytime and nighttime relief in patients with symptoms of chronic gastroesophageal reflux disease
Castell, D
Sigmund, C
Patterson, D
DiMicco, M
Berenson, M
Liebermann, T
Mellow, M
Pruitt, R
Ertan, A
Faruqui, S
Lanza, F
Fitch, D
Shaker, R
Merrell, D
Hasner, D
Clyde, C
Zeldis, J
GASTROENTEROLOGY, 1997, 112 (04) : A84 - A84
[26] A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial
Mulder, CJJ
Westerveld, BD
Smit, JM
Pool, MO
Otten, MH
Tan, TG
de Wit, AWMV
de Groot, GH
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (06) : 649 - 656
[27] HIGH-RISK DUODENAL-ULCER (DU) - LONG-TERM MAINTENANCE TREATMENT (MT) WITH LOW(10MG) AND FULL(20MG) DOSE OMEPRAZOLE (OM) VS RANITIDINE (RAN)
BARDHAN, KD
CHERIAN, P
VAISHNAVI, A
JONES, RB
MORRIS, P
THOMPSON, M
BROOKS, A
DSILVA, J
GILLON, KRW
PARKIN, SA
PATTERSON, J
GASTROENTEROLOGY, 1995, 108 (04) : A53 - A53
[28] Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis
Bate, CM
Green, JRB
Axon, ATR
Murray, FE
Tildesley, G
Emmas, CE
Taylor, MD
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (04) : 755 - 763
[29] Pantoprazole 40mg (Panto) relieves primary reflux symptoms more rapidly than omeprazole mups 20mg (Ome) in patients with severe GERD symptomatology.
Scholten, T
Gatz, G
Sander, P
GASTROENTEROLOGY, 2000, 118 (04) : A1303 - A1303
[30] VALIDITY OF HIGH-DOSE RANITIDINE TREATMENT (300 MG BID) IN CLINICAL-PRACTICE - AN OPEN STUDY IN 68 CONSECUTIVE CASES OF SEVERE PEPTIC DISEASE
GHIDINI, O
ADAMO, S
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1989, 15 (05) : 235 - 238

← 1 2 3 4 →